Dendritic cells become BCR-ABL negative in chronic myeloid leukaemia patients successfully treated with imatinib

被引:5
作者
Wang, L
Butt, NM
Atherton, MG
Clark, RE
机构
[1] Royal Liverpool Univ Hosp, Dept Haematol, Liverpool L7 8XP, Merseyside, England
[2] Liverpool Womens Hosp, Merseyside & Cheshire Cytogenet Lab, Liverpool L8 7SS, Merseyside, England
关键词
D O I
10.1038/sj.leu.2403342
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1025 / 1027
页数:4
相关论文
共 13 条
[1]   Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients [J].
Auffermann-Gretzinger, S ;
Lossos, IS ;
Vayntrub, TA ;
Leong, W ;
Grumet, FC ;
Blume, KG ;
Stockerl-Goldstein, KE ;
Levy, R ;
Shizuru, JA .
BLOOD, 2002, 99 (04) :1442-1448
[2]   Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia [J].
Choudhury, A ;
Gajewski, JL ;
Liang, JC ;
Popat, U ;
Claxton, DF ;
Kliche, KO ;
Andreeff, M ;
Champlin, RE .
BLOOD, 1997, 89 (04) :1133-1142
[3]   Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein [J].
Clark, RE ;
Dodi, IA ;
Hill, SC ;
Lill, JR ;
Aubert, G ;
Macintyre, AR ;
Rojas, J ;
Bourdon, A ;
Bonner, PLR ;
Wang, LH ;
Christmas, SE ;
Travers, PJ ;
Creaser, CS ;
Rees, RC ;
Madrigal, JA .
BLOOD, 2001, 98 (10) :2887-2893
[4]   Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells [J].
Dietz, AB ;
Bulur, PA ;
Erickson, MR ;
Wettstein, PJ ;
Litzow, MR ;
Wyatt, WA ;
Dewald, GW ;
Tefferi, A ;
Pankratz, VS ;
Vuk-Pavlovic, S .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (01) :95-101
[5]   Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration [J].
Dong, R ;
Cwynarski, K ;
Entwistle, A ;
Marelli-Berg, F ;
Dazzi, F ;
Simpson, E ;
Goldman, JM ;
Melo, JV ;
Lechler, RI ;
Bellantuono, I ;
Ridley, A ;
Lombardi, G .
BLOOD, 2003, 101 (09) :3560-3567
[6]  
Eibl B, 1997, GENE CHROMOSOME CANC, V20, P215, DOI 10.1002/(SICI)1098-2264(199711)20:3<215::AID-GCC1>3.0.CO
[7]  
2-5
[8]   Alloreactive CD4(+) T lymphocytes can exert cytotoxicity to chronic myeloid leukaemia cells processing and presenting exogenous antigen [J].
Jiang, YZ ;
Mavroudis, D ;
Dermime, S ;
Hensel, N ;
Couriel, D ;
Molldrem, J ;
Barrett, AJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (03) :606-612
[9]  
MOHTY M, 2004, BLOOD 0108
[10]   Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia [J].
O'Brien, SG ;
Guilhot, F ;
Larson, RA ;
Gathmann, I ;
Baccarani, M ;
Cervantes, F ;
Cornelissen, JJ ;
Fischer, T ;
Hochhaus, A ;
Hughes, T ;
Lechner, K ;
Nielsen, JL ;
Rousselot, P ;
Reiffers, J ;
Saglio, G ;
Shepherd, J ;
Simonsson, B ;
Gratwohl, A ;
Goldman, JM ;
Kantarjian, H ;
Taylor, K ;
Verhoef, G ;
Bolton, AE ;
Capdeville, R ;
Druker, BJ ;
Durrant, S ;
Schwarer, A ;
Joske, D ;
Seymour, J ;
Grigg, A ;
Ma, D ;
Arthur, C ;
Bradstock, K ;
Joshua, D ;
Louwagie, A ;
Martiat, P ;
Straetmans, N ;
Bosly, A ;
Shustik, C ;
Lipton, J ;
Forrest, D ;
Walker, I ;
Roy, DC ;
Rubinger, M ;
Bence-Bruckler, I ;
Kovacs, M ;
Turner, AR ;
Birgens, H ;
Bjerrum, O ;
Facon, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (11) :994-1004